The Europe infusion pumps market is expected to reach US$ 4,969.8 Mn in 2025 from US$ 3,352.4 Mn in 2018. The market is estimated to grow with a CAGR of 5.8% from 2019-2025.
The growth of the infusion pumps market is primarily attributed to the rising incidence of diabetes and rising adoption of insulin injection pens over traditional syringes and vials. However, availability of alternatives for drug delivery is likely to pose a negative impact on the market growth. On the other hand, increasing launch of GLP-1 analogues is likely to have a positive impact on the growth of the Europe infusion pumps market in the coming years.
In recent years, there has been a considerable developments in the field of medical drug delivery devices. Insulin administration is a common procedure in diabetic population. Traditional insulin syringes have several disadvantages that includes experience of pain by patients due to repeated pricks, discomfort in carrying both insulin bottle as well as syringe, risk of needle re-use associated infections and needle-stick injuries as well as difficulty in delivering mixture of two or more liquids together in one syringe. Additionally, self-administration of insulin through syringes and vials is time-taking and difficult that has reduced the adoption of these needles over the past years. On the contrary, pen needles that have emerged as a solution to combat all the existing issues of the needles and vials for drug delivery offer several advantages that has led to rapid shift of patients' preference towards their use. The pre-filled insulin syringes requires minimum steps of selecting the dose volume and attachment of pen needle which is very feasible for patients that practice self-administration of insulin on everyday basis. Moreover, the availability of pen needles in different lengths as well as gauge sizes provide variety of options to the users to find the best suitable option according to their needs. According to a research survey published in Patient Preference and Adherence 2015, approximately 95.2% of patients participated in the survey that inject insulin regularly found pen injection method easy to use hassle-free as compared to conventional vial and syringes use. Thus, owing to above mentioned factors, the market is expected to grow in the coming years.
In 2017, the volumetric pumps segment held a largest market share of 43.7% of the infusion pumps market, by type. The segment is anticipated to witness growth at a substantial rate of 6.1% during the forecast period. This segment is also expected to dominate the market in 2025 owing to its benefits of delivering monitored dosage of medications to the patient. They are being preferred highly in hospitals as they are able to deliver large amount of fluids or medications.
In 2017, the chemotherapy segment held a largest market share of 36.4% of the infusion pumps market, by application. The segment is anticipated to witness the fastest growth rate of 5.7% during the forecast period. This segment is also expected to dominate the market in 2025 owing to increases use of infusion pumps for the administration of medications, to the cancer patients. The pumps for chemotherapy can be used both for inpatient as well as outpatient settings, which makes it a preferable choice for cancer patients.
In 2017, the hospital & clinics segment held a largest market share of 47.5% of the infusion pumps market, by end user. The segment is anticipated to witness the fastest growth rate of 6.2% during the forecast period. This segment is also expected to dominate the market in 2025 owing to rise in the number of surgical procedures as well as reimbursement policies which make the admission process in hospitals a preferred choice.
Some of the major primary and secondary sources for infusion pumps included in the report are, Cancer Research Initiatives Foundation (CARIF), Centers for Disease Control and Prevention (CDC), Clinical Evaluation Report (CER), Food and Drug Administration (FDA), National Institute for Health and Care Excellence (NICE) and others.
TABLE OF CONTENTS
1. INTRODUCTION 18
1.1 Scope of the Study 18
1.2 Publisher Research Report Guidance 18
2. Europe INFUSION PUMPS Market - Key takeaways 20
3. Europe infusion pumps market - market landscape 25
3.1 overview 25
3.2 market segmentation 26
 3.2.1 Europe Infusion Pumps Market - By Type 28
 3.2.2 Europe Infusion Pumps Market - By Application 28
 3.2.3 Europe Infusion Pumps Market - By End User 29
 3.2.4 Europe Infusion Pumps Market - By Country 29
3.3 PEST Analysis 30
4. Europe INFUSION PUMPS market - Key Market Dynamics 34
4.1 Key Market Drivers 34
 4.1.1 Rising Incidence of Diabetes 34
 4.1.2 Rising Adoption of Insulin Injection Pens Over Traditional Syringes and Vials 35
4.2 Key Market Restraints 35
 4.2.1 Availability of Alternatives for Drug Delivery 35
4.3 Key Market Opportunities 36
 4.3.1 Increasing Launch of GLP-1 Analogues 36
4.4 future Trends 36
 4.4.1 Growing Product Innovations 37
4.5 Impact analysis 38
5. INFUSION PUMPS market - Europe Analysis 39
5.1 Europe INFUSION PUMPS market Revenue Forecasts and Analysis 39
5.2 Market positioning 40
5.3 PERFORMANCE OF KEY PLAYERS 41
5.4 expert opinions 43
6. infusion pumps Market - Global Regulatory Scenario 44
 6.1 Europe 44
7. Europe Infusion Pumps market Analysis - By TYPE 46
7.1 Overview 46
7.2 Europe INFUSION PUMPS MARKET, BY Type, 2017 & 2025 (%) 46
7.3 Europe infusion Pumps Market Revenue and Forecasts to 2025, By Type (US$ Mn) 47
 7.3.1 Europe Volumetric Pumps Market Revenue and Forecasts To 2025, By Type (US$ Mn) 48
 7.3.2 Europe Ambulatory Pumps Market Revenue and Forecasts To 2025, By Type (US$ Mn) 48
7.4 Volumetric pumps Market 49
 7.4.1 Overview 49
 7.4.2 Europe Volumetric Pumps Market Revenue And Forecasts To 2025 (US$ Mn) 49
 7.4.3 Elastomeric Pumps Market 51
 7.4.3.1 Overview 51
 7.4.3.2 Europe Elastomeric Pumps Market Revenue And Forecasts To 2025 (US$ Mn) 51
 7.4.4 Smart Pumps Market 53
 7.4.4.1 Overview 53
 7.4.4.2 Europe Smart Pumps Market Revenue And Forecasts To 2025 (US$ Mn) 53
7.5 Syringe pumps Market 55
 7.5.1 Overview 55
 7.5.2 Europe Syringe Pumps Market Revenue And Forecasts To 2025 (US$ Mn) 55
7.6 ambulatory pumps Market 57
 7.6.1 Overview 57
 7.6.2 Europe Ambulatory Pumps Market Revenue And Forecasts To 2025 (US$ Mn) 57
 7.6.3 Insulin Pumps Market 59
 7.6.3.1 Overview 59
 7.6.3.2 Europe Insulin Pumps Market Revenue And Forecasts To 2025 (US$ Mn) 59
 7.6.4 Patient-Controlled Analgesia (PCA) Pumps Market 61
 7.6.4.1 Overview 61
 7.6.4.2 Europe Patient-Controlled Analgesia (PCA) Pumps Market Revenue And Forecasts To 2025 (US$ Mn) 61
 7.6.5 Enteral Pumps Market 63
 7.6.5.1 Overview 63
 7.6.5.2 Europe Enteral Pumps Market Revenue And Forecasts To 2025 (US$ Mn) 63
7.7 accessories Market 65
 7.7.1 Overview 65
 7.7.2 Europe Accessories Market Revenue And Forecasts To 2025 (US$ Mn) 65
8. Europe infusion pumps Market analysis - by application 67
8.1 overview 67
8.2 Europe INFUSION PUMPs, by application 2017 & 2025 (%) 67
8.3 Europe infusion pumps Market revenue and Forecasts to 2025, By application US$ Mn) 68
8.4 Chemotherapy Market 69
 8.4.1 Overview 69
 8.4.2 Europe Chemotherapy Market Revenue And Forecasts To 2025 (US$ Mn) 69
8.5 Diabetes Market 71
 8.5.1 Overview 71
 8.5.2 Europe Diabetes Market Revenue And Forecasts To 2025 (US$ Mn) 71
8.6 Gastrointestinal diseases Market 73
 8.6.1 Overview 73
 8.6.2 Europe Gastrointestinal Diseases Market Revenue And Forecasts To 2025 (US$ Mn) 73
8.7 Pediatrics Market 75
 8.7.1 Overview 75
 8.7.2 Europe Pediatrics Market Revenue And Forecasts To 2025 (US$ Mn) 75
9. Europe infusion pumps market analysis - by end User 77
9.1 overview 77
9.2 Europe Infusion pumps market, by end user 2017 & 2025 (%) 77
9.3 Europe infusion pumps Market Revenue and Forecasts to 2025, By End uSer (US$ Mn) 78
9.4 hospitals & Clinics Market 79
 9.4.1 Overview 79
 9.4.2 Europe Hospitals & Clinics Market Revenue And Forecasts To 2025 (US$ Mn) 79
9.5 Homecare Market 81
 9.5.1 Overview 81
 9.5.2 Europe Homecare Market Revenue And Forecasts To 2025 (US$ Mn) 81
9.6 Ambulatory surgical centers Market 83
 9.6.1 Overview 83
 9.6.2 Europe Ambulatory Surgical Centers Market Revenue And Forecasts To 2025 (US$ Mn) 83
10. Europe infusion pumps market Revenue and Forecasts to 2025 85
10.1 Overview 85
10.2 Europe infusion pumps market Revenue and Forecasts to 2025 (US$ Mn) 87
10.3 Europe Infusion pumps Market Revenue and Forecasts to 2025, By Type (US$ Mn) 88
 10.3.1 Europe Volumetric Pumps Market Revenue and Forecasts To 2025, By Type (US$ Mn) 90
 10.3.2 Europe Ambulatory Pumps Market Revenue and Forecasts To 2025, By Type (US$ Mn) 90
10.4 Europe infusion pumps Market revenue and Forecasts to 2025, By application US$ Mn) 90
10.5 Europe infusion pumps Market Revenue and Forecasts to 2025, By End uSer (US$ Mn) 91
10.6 Europe Infusion pumps market Revenue And Forecasts to 2025, By Country (%) 91
10.7 germany infusion pumps Market Revenue and Forecasts to 2025 (US$ Mn) 93
 10.7.1 Germany Infusion Pumps Market Revenue and Forecasts To 2025 (US$ Mn) 93
 10.7.2 Germany Infusion Pumps Market Revenue And Forecasts To 2025, By Type (US$ Mn) 94
 10.7.2.1 Germany Volumetric Pumps Market Revenue And Forecasts To 2025, By Type (US$ Mn) 95
 10.7.2.2 Germany Ambulatory Pumps Market Revenue And Forecasts To 2025, By Type (US$ Mn) 95
 10.7.3 Germany Infusion Pumps Market Revenue And Forecasts To 2025, By Application (US$ Mn) 96
 10.7.4 Germany Infusion Pumps Market Revenue and Forecasts To 2025, By End User (US$ Mn) 96
10.8 Uk infusion pumps Market Revenue and Forecasts to 2025 (US$ Mn) 97
 10.8.1 UK Infusion Pumps Market Revenue and Forecasts To 2025 (US$ Mn) 97
 10.8.2 UK Infusion Pumps Market Revenue And Forecasts To 2025, By Type (US$ Mn) 98
 10.8.2.1 UK Volumetric Pumps Market Revenue And Forecasts To 2025, By Type (US$ Mn) 99
 10.8.2.2 UK Ambulatory Pumps Market Revenue And Forecasts To 2025, By Type (US$ Mn) 99
 10.8.3 UK Infusion Pumps Market Revenue And Forecasts To 2025, By Application (US$ Mn) 100
 10.8.4 UK Infusion Pumps Market Revenue and Forecasts to 2025, By End User (US$ Mn) 100
10.9 France Infusion Pumps Market Revenue and Forecasts to 2025 (US$ Mn) 101
 10.9.1 France Infusion Pumps Market Revenue and Forecasts To 2025 (US$ Mn) 101
 10.9.2 France Infusion Pumps Market Revenue And Forecasts To 2025, By Type (US$ Mn) 102
 10.9.2.1 France Volumetric Pumps Market Revenue And Forecasts To 2025, By Type (US$ Mn) 103
 10.9.2.2 France Ambulatory Pumps Market Revenue And Forecasts To 2025, By Type (US$ Mn) 103
 10.9.3 France Infusion Pumps Market Revenue And Forecasts To 2025, By Application (US$ Mn) 104
 10.9.4 France Infusion Pumps Market Revenue and Forecasts To 2025, By End User (US$ Mn) 104
11. Infusion Pumps MARKET - Industry Landscape 105
11.1 Overview 105
11.2 Growth Strategies in the Infusion pumps Market, 2015-2018 105
11.3 Organic Developments 106
 11.3.1 Overview 106
11.4 Organic Growth Strategies in the INFUSION PUMPS Market, 2016-2018 106
11.5 Product Launch 107
 11.5.1 Recent Product Launch By Players In The Infusion Pumps Market 107
11.6 Product approval 108
 11.6.1 Recent Product Approval By Players In The Infusion Pumps Market 108
11.7 Expansion & Others 109
 11.7.1 Infusion Pumps Market By Expansion & Other Growth Strategies 109
11.8 Inorganic developments 110
 11.8.1 Overview 110
11.9 inOrganic Growth Strategies in the Infusion Pumps Market, 2015-2018 110
11.10 Acquisitions 111
 11.10.1 Acquisitions By Players In The Infusion Pumps Market 111
11.11 Agreements 112
 11.11.1 Infusion Pumps Market By Agreements 112
11.12 Partnership 112
 11.12.1 Partnership By Players In The Infusion Pumps Market 112
12. INFUSION PUMPS Market - Key company profiles 114
 12.1 BD 114
 12.1.1 Key Facts 114
 12.1.2 Business Description 114
 12.1.3 Financial Overview 115
 12.1.4 Product Portfolio 116
 12.1.5 SWOT Analysis 117
 12.1.6 Key Developments 117
12.2 B. Braun Melsungen AG 119
 12.2.1 Key Facts 119
 12.2.2 Business Description 119
 12.2.3 Financial Overview 120
 12.2.4 Product Portfolio 121
 12.2.5 SWOT Analysis 122
 12.2.6 Key Developments 122
12.3 Terumo Corporation 124
 12.3.1 Key Facts 124
 12.3.2 Business Description 124
 12.3.3 Financial Overview 125
 12.3.4 Product portfolio 125
 12.3.5 SWOT ANALYSIS 126
 12.3.6 KEY DEVELOPMENTS 127
12.4 F. Hoffmann-La Roche Ltd. 128
 12.4.1 Key Facts 128
 12.4.2 Business Description 128
 12.4.3 Financial Overview 129
 12.4.4 Product Portfolio 130
 12.4.5 SWOT Analysis 130
 12.4.6 Key Developments 131
12.5 Medtronic 132
 12.5.1 Key Facts 132
 12.5.2 Business Description 132
 12.5.3 Financial Information 133
 12.5.4 Product Portfolio 134
 12.5.5 SWOT Analysis 135
 12.5.6 Key Developments 135
12.6 BAxter International, Inc. 138
 12.6.1 Key Facts 138
 12.6.2 Business Description 138
 12.6.3 Financial Overview 140
 12.6.4 Product Portfolio 140
 12.6.5 SWOT Analysis 141
 12.6.6 Key Developments 141
12.7 Smith Medical 143
 12.7.1 Key Facts 143
 12.7.2 Business Description 143
 12.7.3 Financial Overview 144
 12.7.4 Product Portfolio 145
 12.7.5 SWOT Analysis 147
 12.7.6 Key Developments 148
12.8 moog, inc 149
 12.8.1 Key Facts 149
 12.8.2 Business Description 149
 12.8.3 Financial Overview 150
 12.8.4 Product Portfolio 151
 12.8.5 SWOT Analysis 151
 12.8.6 Key Developments 152
12.9 ICu Medical, Inc. 153
 12.9.1 Key Facts 153
 12.9.2 Business Description 153
 12.9.3 Financial Overview 154
 12.9.4 Product Portfolio 155
 12.9.5 SWOT Analysis 156
 12.9.6 Key Developments 156
12.10 Insulet Corporation 157
 12.10.1 Key Facts 157
 12.10.2 Business Description 157
 12.10.3 Financial Information 158
 12.10.4 Product Portfolio 159
 12.10.5 SWOT Analysis 159
 12.10.6 Key Developments 160
13. Appendix 162
13.1 About Publisher 162
13.2 Glossary of Terms 162
13.3 Methodology 166
 13.3.1 Coverage 168
 13.3.2 Secondary Research 168
 13.3.3 Primary Research 169
LIST OF TABLES
LIST OF FIGURES
The List of Companies
1. BD
2. Terumo Corporation
3. F. Hoffman-La Roche Ltd
4. B. Braun Melsungen AG
5. Medtronic
6. Baxter
7. Smith Medical
8. Moog Inc.
9. ICU Medical, Inc.
10. Insulet Corporation.